Lai Wang insider trades

Open-market stock purchases and sales by Lai Wang, President, Global Head of R&D at BeOne Medicines Ltd, from SEC Form 4 filings since Jun 7, 2021.

Recent trades

DateStockTradeValue
Jun 23, 2026ONC BeOne Medicines LtdSold$296K
Jun 16, 2026ONC BeOne Medicines LtdSold$310K
Jun 11, 2026ONC BeOne Medicines LtdBought (not open market)—
Jun 11, 2026ONC BeOne Medicines LtdSold$197K
Jun 11, 2026ONC BeOne Medicines LtdBought (not open market)—
Jun 8, 2026ONC BeOne Medicines LtdSold$357K
Jun 8, 2026ONC BeOne Medicines LtdSold$10.8K
Mar 6, 2026ONC BeOne Medicines LtdBought (not open market)—
Mar 6, 2026ONC BeOne Medicines LtdBought (not open market)—
Dec 31, 2025ONC BeOne Medicines LtdBought (not open market)—

Companies traded

  • ONC BeOne Medicines Ltd: 17 sales, last Jun 23, 2026
  • BGNE BeiGene, Ltd: 28 sales, last Mar 5, 2025

Get free alerts when Lai Wang files a new trade →